BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10413018)

  • 1. 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in propionic acidemia: clinical and MRI correlations.
    Al-Essa M; Bakheet S; Patay Z; Al-Shamsan L; Al-Sonbul A; Al-Watban J; Powe J; Ozand PT
    Brain Dev; 1999 Jul; 21(5):312-7. PubMed ID: 10413018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
    Al-Essa M; Bakheet S; Al-Shamsan L; Patay Z; Powe J; Ozand PT
    Brain Dev; 1999 Jan; 21(1):24-9. PubMed ID: 10082249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in glutaric aciduria type 1: clinical and MRI correlations.
    Al-Essa M; Bakheet S; Patay Z; Al-Watban J; Powe J; Joshi S; Ozand PT
    Brain Dev; 1998 Aug; 20(5):295-301. PubMed ID: 9760998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and brain 18fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease.
    al-Essa MA; al-Shamsan LA; Ozand PT
    Eur J Paediatr Neurol; 1999; 3(3):125-7. PubMed ID: 10461568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lenticular nuclei to thalamic ratio on PET is useful for diagnosis of GLUT1 deficiency syndrome.
    Natsume J; Ishihara N; Azuma Y; Nakata T; Takeuchi T; Tanaka M; Sakaguchi Y; Okai Y; Ito Y; Yamamoto H; Ohno A; Kidokoro H; Hattori A; Nabatame S; Kato K
    Brain Dev; 2021 Jan; 43(1):69-77. PubMed ID: 32739099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
    Brockmann K; Reimold M; Globas C; Hauser TK; Walter U; Machulla HJ; Rolfs A; Schöls L
    J Nucl Med; 2012 Jul; 53(7):1074-80. PubMed ID: 22653791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: clinical and biochemical considerations.
    Bergman AJ; Van der Knaap MS; Smeitink JA; Duran M; Dorland L; Valk J; Poll-The BT
    Pediatr Res; 1996 Sep; 40(3):404-9. PubMed ID: 8865276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT and MR of the brain in disorders of the propionate and methylmalonate metabolism.
    Brismar J; Ozand PT
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1459-73. PubMed ID: 7985563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease.
    Al-Essa MA; Bakheet SM; Patay ZJ; Powe JE; Ozand PT
    Brain Dev; 2000 Mar; 22(2):127-31. PubMed ID: 10722966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients.
    Brismar J; Ozand PT
    Brain Dev; 1994 Nov; 16 Suppl():104-24. PubMed ID: 7726375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?
    Chiapparini L; Granata T; Farina L; Ciceri E; Erbetta A; Ragona F; Freri E; Fusco L; Gobbi G; Capovilla G; Tassi L; Giordano L; Viri M; Dalla Bernardina B; Spreafico R; Savoiardo M
    Neuroradiology; 2003 Mar; 45(3):171-83. PubMed ID: 12684722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
    Silverman DH
    J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis.
    Al-Essa MA; Bakheet SM; Patay ZJ; Nounou RM; Ozand PT
    Brain Dev; 1999 Dec; 21(8):559-62. PubMed ID: 10598059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas: an ultra-high resolution PET/MRI fusion study using 18F-FDG.
    Kim JH; Son YD; Kim JM; Kim HK; Kim YB; Lee C; Oh CH
    Braz J Med Biol Res; 2017 Nov; 51(1):e6724. PubMed ID: 29160415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study.
    Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU
    Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J; Peppard R; Calne DB
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance and positron emission tomography changes during the clinical progression of Rasmussen encephalitis.
    Kaiboriboon K; Cortese C; Hogan RE
    J Neuroimaging; 2000 Apr; 10(2):122-5. PubMed ID: 10800268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.